venBio Global Strategic Fund IV, L.P.

Insider · 10% owner · ATTO

venBio Global Strategic Fund IV, L.P. files insider transactions with the SEC as a 10% owner of Attovia Therapeutics. We hold 1 disclosed purchase or sale filed since 10 August 2026, 1 of them in the last 90 days.

Files forATTO
Disclosed buys and sells1 in all, 1 in the last 90 days
Last disclosure10 August 2026

Positions held

1 post we hold — a term names its own dates; a run of filings only says when they filed

Filed 6 August 2026 — 6 August 202610% owner · Attovia Therapeutics 7 Form 4 lines · source: SEC Form 4

Every transaction

7 transactions from SEC Form 4 — one row each, sort any column, open a row for the filing

Sort byOpen-market trades only7 of 7 shown


6 Aug 2026	10 Aug 2026SEC Form 4	4 d	convertednot a trade	Attovia Therapeutics	2,311,870 shares	up +12.2%	up +15.2%
6 Aug 2026	10 Aug 2026SEC Form 4	4 d	convertednot a trade	Attovia Therapeutics	821,998 shares	up +12.2%	up +15.2%
6 Aug 2026	10 Aug 2026SEC Form 4	4 d	convertednot a trade	Attovia Therapeutics	665,147 shares	up +12.2%	up +15.2%
6 Aug 2026	10 Aug 2026SEC Form 4	4 d	bought on the open market	Attovia Therapeutics	382,352 shares	up +12.2%	up +15.2%
6 Aug 2026	10 Aug 2026SEC Form 4	4 d	convertednot a trade	Attovia Therapeuticsderivative	21,477,273 shares	up +12.2%	up +15.2%
6 Aug 2026	10 Aug 2026SEC Form 4	4 d	convertednot a trade	Attovia Therapeuticsderivative	7,636,362 shares	up +12.2%	up +15.2%
6 Aug 2026	10 Aug 2026SEC Form 4	4 d	convertednot a trade	Attovia Therapeuticsderivative	6,179,219 shares	up +12.2%	up +15.2%

Both percentages are the stock’s move, not venBio Global Strategic Fund IV, L.P.’s return: a disclosure gives a band, never an amount, so nobody can say how much was bought or what it made. They run to the last close we hold — 9 Sep 2026, except where a name has since delisted, when the row names its own last session. We publish no close, no volume and no dollar figure behind them. 7 of the 7 rows shown carry a percentage; the rest are dashes with the reason on the row.

Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.

Some filings reach us as photographs of paper rather than as a form we can read as text. Those are shown here only once they have been read and checked, so this page can hold fewer lines than the filings behind it contain. The link on every row opens the original document, which is always the full record.